Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Cell Reports|September 21, 2022
Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitorsLetizia Granieri, Federica Marocchi, Marine Melixetian, et al.
Blood|June 9, 2023
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cellsValentina Vavassori, Samuele Ferrari, Stefano Beretta, et al.
Science Signaling|April 4, 2019
Proteomics profiling of arginine methylation defines PRMT5 substrate specificityDaniele Musiani, Jabez Bok, Enrico Massignani, et al.
Chemical Biology & Drug Design|July 28, 2011
A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptorsRoberta Noberini, Surya K De, Ziming Zhang, et al.
The EMBO Journal|November 4, 2018
The kinetochore module Okp1<sup>CENP-Q</sup>/Ame1<sup>CENP-U</sup> is a reader for N-terminal modifications on the centromeric histone Cse4<sup>CENP-A</sup>Ekaterina A Anedchenko, Anke Samel-Pommerencke, Tra My Tran Nguyen, et al.
Chemmedchem|April 25, 2012
Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptorMassimiliano Tognolini, Matteo Incerti, Iftiin Hassan-Mohamed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2012
Targeted delivery of paclitaxel to EphA2-expressing cancer cellsSi Wang, Roberta Noberini, John L Stebbins, et al.
Journal of Medicinal Chemistry|March 16, 2013
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptorMatteo Incerti, Massimiliano Tognolini, Simonetta Russo, et al.
EMBO Reports|February 15, 2021
Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translationMarine Melixetian, Daniela Bossi, Marija Mihailovich, et al.
Pageof 15